Skip to main content
OpenTrials
Completed

NCT Number: NCT02855606

Acceptability of HIV Oral PrEP Among MSM and TGW

The purpose of this study is to determine the factors associated with acceptability to oral HIV pre-exposure prophylaxis (PrEP) among Thai men who have sex with men (MSM) and transgender women (TGW).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patient Acceptance of Health Care Behavior Health Behavior Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Piman Center

Chiang Mai, 50200, Thailand

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • MSM or TGW at age18 years or older at enrollment
  • Able to read and write effectively in Thai language
  • Negative HIV testing (by assigned rapid tests) at enrollment
  • Available to return for the study visits and willing to comply with study requirements
  • Willing to provide reachable contact numbers and address
  • Creatinine clearance ≥ 60 mL/min
  • Negative urine protein
  • Negative HBs Ag

Exclusion criteria

  • Symptoms suggestive for acute HIV seroconversion
  • Participating in any interventional HIV research
  • Has any physical or mental condition(s) that, in the opinion of the investigator(s), complicate interpretation of study outcome data

Treatment and study plan

Primary outcomes

  1. Acceptability and factors affecting the decision to take oral PrEP

    Time frame: 1 year

    After receiving information about PrEP, the participants will have a chance to decide whether they want to take PrEP or not. The set of questions asking about reason(s) for taking (or not taking) PrEP are used to evaluated the acceptability. The questions will evaluate multiple aspects such as knowledge about PrEP (efficacy and medications side effect), personal belief about PrEP, sexual practice, social stigmata, and concern for HIV resistance. The participants will answer these questions via Computer-Assisted Self Interviewing (CASI).

Secondary outcomes

  1. Adherence to PrEP by self-report

    Time frame: 1 year

    Among the participants who decide to take PrEP, the adherence will be evaluate by self-report (directly to medical staff and via Computer-Assisted Self Interviewing).

  2. Adherence to PrEP by pill count

    Time frame: 1 year

    Among the participants who decide to take PrEP, the adherence will be evaluate by pill count.

Sponsors and collaborators

Lead sponsor

Chiang Mai University

Other

Registry information

Official study title

Acceptability of HIV Oral Pre-Exposure Prophylaxis (PrEP) Among Men Have Sex With Men (MSM) and Transgender Women (TGW)

Important dates

Study start
2015
Primary completion
2018
Study completion
2019
First posted
Aug 4, 2016
Registry last updated
Jul 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.